Resources

This document provides guidance to developers and manufacturers on the key performance requirements and potential design approaches for the development of a reliable, robust, and scalable oxygen concentrator that is appropriate for treatment of pediatric patients with hypoxemia in low-level facilities in low-resource settings.

This messaging framework is designed to help identify and design advocacy strategies related to the promotion of pharmacies and drug shops. It includes key messages across audiences and provides talking points for targeted communications and interactions with priority audiences.

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations manufactured using a standard lyophilization process. The tablets are packaged in unit-dose blisters, offering an inexpensive, scalable, and easy-to-use presentation for live attenuated vaccines containing single or multiple bacterial strains. Further, the stackable design may minimize product volume and thus the space required for storage and transport, resulting in significant savings for health systems and cold chains.

At PATH, we are working to identify and track indicators to assess our performance across five primary innovation platforms: vaccines, drugs, diagnostics, devices, and system and service innovations. This fact sheet provides a summary of our efforts to measure impact.

This fact sheet contains information about PATH's monitoring and evaluation (M&E) department, including work on strengthening measurement tools and systems, strengthening individual skill and expertise, and providing technical assistance.